Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne A Ray

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Paediatric and Perinatal Epidemiology|February 21, 2009
Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformationsWilliam O Cooper, Sonia Hernandez-Diaz, Patrick G Arbogast, et al.
JAMA|April 15, 2024
Serious Bleeding in Patients With Atrial Fibrillation Using Diltiazem With Apixaban or RivaroxabanWayne A Ray, Cecilia P Chung, C Michael Stein, et al.
JAMA|December 21, 2021
Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial FibrillationWayne A Ray, Cecilia P Chung, C Michael Stein, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart diseaseWayne A Ray, Cristina Varas-Lorenzo, Cecilia P Chung, et al.
Annals of Internal Medicine|May 22, 2023
Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation : A Retrospective Cohort StudyWayne A Ray, Cecilia P Chung, C Michael Stein, et al.
Pharmacoepidemiology and Drug Safety|August 17, 2019
Individual short-acting opioids and the risk of opioid-related adverse events in adolescentsCecilia P Chung, Stephen Todd Callahan, William O Cooper, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
Brief report: Risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancyWilliam O Cooper, T Craig Cheetham, De-Kun Li, et al.
Pediatrics|July 18, 2018
Outpatient Opioid Prescriptions for Children and Opioid-Related Adverse EventsCecilia P Chung, S Todd Callahan, William O Cooper, et al.
Clinical Pharmacology and Therapeutics|February 5, 2026
Association of Pregabalin vs. Duloxetine with Cardiovascular Events: A Retrospective Cohort Study Among US Veterans With Chronic Musculoskeletal PainSachalee Campbell, Puran Nepal, Laura Daniel, et al.
The Clinical Journal of Pain|April 24, 2023
Duloxetine, Gabapentin, and the Risk for Acute Myocardial Infarction, Stroke, and Out-of-Hospital Death in Medicare Beneficiaries With Non-Cancer PainMeghan A Corriere, Alyson L Dickson, Laura L Daniel, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Paediatric and Perinatal Epidemiology|February 21, 2009
Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformationsWilliam O Cooper, Sonia Hernandez-Diaz, Patrick G Arbogast, et al.
JAMA|April 15, 2024
Serious Bleeding in Patients With Atrial Fibrillation Using Diltiazem With Apixaban or RivaroxabanWayne A Ray, Cecilia P Chung, C Michael Stein, et al.
JAMA|December 21, 2021
Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial FibrillationWayne A Ray, Cecilia P Chung, C Michael Stein, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart diseaseWayne A Ray, Cristina Varas-Lorenzo, Cecilia P Chung, et al.
Annals of Internal Medicine|May 22, 2023
Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation : A Retrospective Cohort StudyWayne A Ray, Cecilia P Chung, C Michael Stein, et al.
Pharmacoepidemiology and Drug Safety|August 17, 2019
Individual short-acting opioids and the risk of opioid-related adverse events in adolescentsCecilia P Chung, Stephen Todd Callahan, William O Cooper, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
Brief report: Risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancyWilliam O Cooper, T Craig Cheetham, De-Kun Li, et al.
Pediatrics|July 18, 2018
Outpatient Opioid Prescriptions for Children and Opioid-Related Adverse EventsCecilia P Chung, S Todd Callahan, William O Cooper, et al.
Clinical Pharmacology and Therapeutics|February 5, 2026
Association of Pregabalin vs. Duloxetine with Cardiovascular Events: A Retrospective Cohort Study Among US Veterans With Chronic Musculoskeletal PainSachalee Campbell, Puran Nepal, Laura Daniel, et al.
The Clinical Journal of Pain|April 24, 2023
Duloxetine, Gabapentin, and the Risk for Acute Myocardial Infarction, Stroke, and Out-of-Hospital Death in Medicare Beneficiaries With Non-Cancer PainMeghan A Corriere, Alyson L Dickson, Laura L Daniel, et al.
Pageof 10